4.6 Article

Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by toll-like receptor 2:: Role of N-terminal hydrophobic portion in its multiple functions

Journal

JOURNAL OF IMMUNOLOGY
Volume 166, Issue 4, Pages 2610-2616

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.166.4.2610

Keywords

-

Categories

Ask authors/readers for more resources

M161Ag is a 43-kDa surface lipoprotein of Mycoplasma fermentans, serving as a patent cytokine inducer for monocytes/macrophages, maturing dendritic cells (DCs), and activating host complement on affected cells, It possesses a unique N-terminal lipo-amino acid, S-diacylglyceryl cysteine. The 2-kDa macrophage-activating lipopeptide-2 (MALP-2), recently identified as a ligand for Toll-like receptor 2 (TLR2), is derived from M161Ag. In this study, we identified structural motifs sustaining the functions of M161Ag using wild-type and unlipidated rM161Ag with (SPC) or without signal peptides (SP-). Because the SP+ rM161Ag formed dimers via 25Cys, we obtained a monomeric form by mutagenesis (SP(+)C25S). Only wild type accelerated maturation of human DCs as determined by the CDS3/86 criteria, suggesting the importance of the N-terminal fatty acids for this function. Wild-type and the SP+ form of monomer induced secretion of TNF-alpha and Il-12 p40 by human monocytes and DCs. Either lipid or signal peptide at the N-terminal portion of monomer was required for expression of this function, In contrast, murine macraphages produced TNF-alpha in response to mild type, but not to any recombinant form of M161Ag suggesting the species-dependent response to rM161Ag. Wild-type and both monomeric and dimeric SP+ forms possessed the ability to activate complement via the alternative pathway, Again, the hydrophobic portion was associated with this function. These results, together with the finding that macrophages from TLR2-deficient mice did not produce TNF-alpha in response to M161Ag, infer that the N-terminal hydrophobic structure of M161Ag is important for TLR2-mediated cell activation and complement activation. The Journal of Immunology, 2001, 166: 2610-2616.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available